Prolonged outbreak of human parainfluenza virus 3 infection in a stem cell transplant outpatient department: Insights from molecular epidemiologic analysis

Biology of Blood and Marrow Transplantation

Volumn 10, Issue 1, 2004, Pages 58-64

  Nichols, W Garrett ^a   Erdman, Dean D ^b   Han, Alison ^b   Zukerman, Carol ^c   Corey, Lawrence ^a   Boeckh, Michael ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c SWEDISH MEDICAL CENTER   (United States)

Author keywords

Nosocomial transmission; Parainfluenza; Stem cell transplantation

Indexed keywords

HN PROTEIN;

ARTICLE; CONTROLLED STUDY; ENVIRONMENT; EPIDEMIC; FOLLOW UP; HOSPITAL INFECTION; HOSPITAL PATIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; MAJOR CLINICAL STUDY; MEDICAL STAFF; MORBIDITY; MORTALITY; NUCLEOTIDE SEQUENCE; OUTPATIENT DEPARTMENT; PARAINFLUENZA VIRUS 3; RECIPIENT; RNA VIRUS INFECTION; SEQUENCE ANALYSIS; STEM CELL TRANSPLANTATION; SYMPTOMATOLOGY; VIRUS ISOLATION; VIRUS SHEDDING; VIRUS TRANSMISSION;

CROSS INFECTION; DISEASE OUTBREAKS; EPIDEMIOLOGY, MOLECULAR; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOSPITAL DEPARTMENTS; HUMANS; IMMUNOCOMPROMISED HOST; INCIDENCE; PARAINFLUENZA VIRUS 3, HUMAN; RESPIROVIRUS INFECTIONS; RNA, VIRAL; SEQUENCE ANALYSIS, RNA; WASHINGTON;

EID: 0742271413     PISSN: 10838791     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbmt.2003.09.010     Document Type: Article

References (22)

1. Nichols W.G. Gooley T. Boeckh M. Community-acquired respiratory syncytial virus and parainfluenza virus infections after hematopoietic stem cell transplantation: the Fred Hutchinson Cancer Research Center experience Biol Blood Marrow Transplant. 7suppl 2001 11S-15S
2. Lewis V.A. Champlin R. Englund J. et al. Respiratory disease due to parainfluenza virus in adult bone marrow transplant recipients Clin Infect Dis. 23 1996 1033-1037
3. Wendt C.H. Weisdorf D.J. Jordan M.C. Balfour H.H. Jr. Hertz M.I. Parainfluenza virus respiratory infection after bone marrow transplantation N Engl J Med. 326 1992 921-926
4. Nichols W.G. Corey L. Gooley T. Davis C. Boeckh M. Parainfluenza virus infections after hematopoietic stem cell transplantation: risk factors, response to antiviral therapy, and effect on transplant outcome Blood 98 2001 573-578
5. Zambon M. Bull T. Sadler C.J. Goldman J.M. Ward K.N. Molecular epidemiology of two consecutive outbreaks of parainfluenza 3 in a bone marrow transplant unit J Clin Microbiol. 36 1998 2289-2293
6. Cortez K.J. Erdman D.D. Peret T.C. et al. Outbreak of human parainfluenza virus 3 infections in a hematopoietic stem cell transplant population J Infect Dis. 184 2001 1093-1097
7. Buckner C.D. Clift R.A. Appelbaum F.R. et al. Effects of treatment regimens in patients allografted for acute and chronic myelogenous leukemia Bone Marrow Transplant. 7 1991 6-8
8. Clift R.A. Buckner C.D. Thomas E.D. et al. Marrow transplantation for chronic myeloid leukemia: a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide Blood 84 1994 2036-2043
9. Lynch M.H. Petersen F.B. Appelbaum F.R. et al. Phase II study of busulfan, cyclophosphamide and fractionated total body irradiation as a preparatory regimen for allogeneic bone marrow transplantation in patients with advanced myeloid malignancies Bone Marrow Transplant. 15 1995 59-64
10. Deeg H.J. Lin D. Leisenring W. et al. Cyclosporine or cyclosporine plus methylprednisolone for prophylaxis of graft-versus-host disease: a prospective, randomized trial Blood 89 1997 3880-3887
11. Storb R. Leisenring W. Deeg H.J. et al. Long-term follow-up of a randomized trial of graft-versus-host disease prevention by methotrexate/cyclosporine versus methotrexate alone in patients given marrow grafts for severe aplastic anemia [letter] Blood 83 1994 2749-2750
12. Tyrrell D.A.J. Bynoe M.L. Petersen K.B. Sutton R.N.P. Pereira M.S. Inoculation of human volunteers with parainfluenza viruses types 1 and 3 (HA2 and HA1) Br Med J. 2 1959 909-911
13. van Wyke Coelingh K.L. Winter C.C. Murphy B.R. Nucleotide and deduced amino acid sequence of hemagglutinin-neuraminidase genes of human type 3 parainfluenza viruses isolated from 1957 to 1983 Virology 162 1988 137-143
14. Karron R.A. O'Brien K.L. Froehlich J.L. Brown V.A. Molecular epidemiology of a parainfluenza type 3 virus outbreak on a pediatric ward J Infect Dis. 167 1993 1441-1445
15. Adams R.H. Preemptive treatment of pediatric bone marrow transplant patients with asymptomatic respiratory syncytial virus infection with aerosolized ribavirin Biol Blood Marrow Transplant. 7 suppl 2001 16S-18S
16. Ljungman P. Gleaves C.A. Meyers J.D. Respiratory virus infection in immunocompromised patients Bone Marrow Transplant. 4 1989 35-40
17. Henrickson K.J. Parainfluenza viruses Clin Microbiol Rev. 16 2003 242-264
18. Brady M.T. Evans J. Cuartas J. Survival and disinfection of parainfluenza viruses on environmental surfaces Am J Infect Control 18 1990 18-23
19. Hall C.B. Long C.E. Schnabel K.C. Respiratory syncytial virus infections in previously healthy working adults Clin Infect Dis. 33 2001 792-796
20. Kapikian A.Z. Chanock R.M. Reichelderfer T.E. Ward T.G. Huebner R.J. Bell J.A. Inoculation of human volunteers with parainfluenza virus type 3 JAMA. 178 1961 537-541
21. Muchmore H.G. Parkinson A.J. Humphries J.E. et al. Persistent parainfluenza virus shedding during isolation at the South Pole Nature 289 1981 187-189
22. Frank A.L. Taber L.H. Wells C.R. Wells J.M. Glezen W.P. Paredes A. Patterns of shedding of myxoviruses and paramyxoviruses in children J Infect Dis. 144 1981 433-441